This is a revised disclosure filed with BSE Limited regarding the outcome of the Board of Directors meeting held on July 4, 2026. The filing serves to include an agenda item that was omitted from the original submission made on July 4, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The additional agenda item approved by the Board was: "To approve the change in the name of the Company from 'Sarda Proteins Limited' to such other name as may be approved by the Central Registration Centre (CRC), Ministry of Corporate Affairs, and consequent alteration of the Memorandum of Association and Articles of Association of the Company."
The Board meeting was held at the company's Registered Office, commencing at 3:00 p.m. and concluding at 5:40 p.m. The final name change is contingent upon approval from the Central Registration Centre (CRC) of the Ministry of Corporate Affairs.
The letter is signed by Mr. Shirish Dhirajlal Savaliya, Managing Director (DIN: 08721554), and requests the exchange to take this additional agenda item on record alongside the other items approved in the original July 4, 2026 filing.